NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Phlow Corp.

Phlow Corp.

Private
Richmond, VirginiaHealthcare & Life Scienceshttps://www.phlow-usa.com/

Last Round

Series C

Jul 22, 2025

Total Funding Raised

$447M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Phlow Corp. is a pharmaceutical company that provides contract development and manufacturing of active pharmaceutical ingredients and essential medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Smart Manufacturing, Clean Manufacturing

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

active pharmaceutical ingredientAPICDMOcontract manufacturingcontinuous manufacturingdomestic drug manufacturingpharmaceutical supply chainreshoring pharmaessential medicinesdrug shortage preventionpharmaceutical resilienceB2Ggovernment contractingsmart manufacturingAI-driven manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phlow Corp. Comparables

Compare Phlow Corp. with similar companies based on industry and business-model similarity.

Phlow Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Path Laboratories
88%
CONTINUUS Pharmaceuticals
81%
Antheia
79%
View all Comparables

Phlow Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 22, 2025
Series BApr 5, 2023
Series AFeb 16, 2021
GrantMay 18, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

David Ryan

Chief Financial Officer

Executive Team

Phlow Corp. Investors

Notable investors and investment history

Phlow Corp. investors
InvestorRounds
Public Health Emergency Medical Countermeasures EnterpriseGrant
Align Private CapitalSeries C
Biomedical Advanced Research and Development Authority (BARDA)Grant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    Dawn Von Rohr appointed as the new COO.

  • Mar 18, 2026

    Partnering with Fresenius Kabi for API production and final formulation.

View all signals

Phlow Corp. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Phlow Corp. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersRichmond, Virginia
Employee Range115
Year Founded2020
Last FundingJul 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.